IN THE NEWS

CDMO

Overcoming Manufacturing Challenges for Ophthalmic Drugs

Preservatives like benzalkonium chloride can irritate the eye, especially with long-term use. Removing them makes manufacturing even more important. Learn how sterile Blow-Fill-Seal (BFS) technology and single-unit packaging help ophthalmic drug developers maintain microbial control without relying on preservatives.
READ MORE
Strips of single-use plastic unit-dose vials moving through a rotating machine on a pharmaceutical production line, with a cutout of a five-vial Blow-Fill-Seal strip in the corner. Overlay text reads “Overcoming manufacturing challenges for ophthalmic drugs” with the Ritedose logo.

What Ophthalmic Drug Developers Need in a CDMO

Clinical success is only the beginning. For ophthalmic drug developers, the right CDMO can help turn clinical progress into a scalable, sterile, high-quality manufacturing strategy built for commercialization.
READ MORE
Two cartons of YUVEZZI ophthalmic product moving along a conveyor belt in a pharmaceutical manufacturing facility, with a masked worker in the background. Overlay text reads "What do ophthalmic drug developers need in a CDMO?" with the Ritedose logo.
FEATURED NEWS
RECEIVE THE LATEST NEWS

Get a healthy dose of all things Ritedose. Subscribe now for breaking news alerts, updates, previews, and more.

Please enter a valid email address.
TAGS CLOUD

Accessibility